Skip to main content
SpringerLink
Log in

Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients

  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Aberrant methylation of some cancer-related genes has been reported to correlate with sensitivity to chemotherapeutic agents. The present study was designed to determine whether DNA methylation in six cancer-related genes affects recurrence of gastric cancer in patients who received 5-fluorouracil-based adjuvant chemotherapy.

Methods

The methylation status of six genes, MGMT, CHFR, hMLH1, p16INK4a, E-cadherin, and Runx3, was analyzed in 56 surgically resected gastric cancer tissue specimens by methylation-specific polymerase chain reaction. Of the 56 patients who underwent surgical resection, 38 received 5-fluorouracil (5-FU)-based adjuvant chemotherapy postoperatively (adjuvant group), whereas the other 18 (32%) did not (surgery group).

Results

There were no significant differences between the two groups with respect to sex, cancer differentiation, depth of tumor invasion, lymph node metastasis, lymphatic invasion, vascular invasion and tumor stage. Among the genes, methylation of p16INK4a showed a significant correlation with longer survival in the 38 patients of the adjuvant group, but not in the 18 patients of the surgery group. A multivariate analysis identified p16INK4a methylation to be an independent factor predicting a longer recurrence-free period under 5-FU-based adjuvant chemotherapy.

Conclusions

The present study demonstrated for the first time that gastric cancer patients with p16INK4a methylation specifically benefit from 5-FU-based adjuvant chemotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. A Jemal R Siegei E Ward T Murray J Xu MJ Thun (2007) ArticleTitleCancer statistics, 2007 CA Cancer J Clin 57 43–66 Occurrence Handle17237035 Occurrence Handle10.3322/canjclin.57.1.43

    Article  PubMed  Google Scholar 

  2. K Oba S Morita A Tsuburaya Y Kodera M Kobayashi J Sakamoto (2006) ArticleTitleEfficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: a meta-analysis of centrally randomized controlled clinical trials J Chemother 18 311–7 Occurrence Handle17129844 Occurrence Handle1:CAS:528:DC%2BD28XotFart78%3D

    PubMed  CAS  Google Scholar 

  3. P Schoffski (2004) ArticleTitleThe modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and solid tumors Anticancer Drugs 15 85–106 Occurrence Handle15075664 Occurrence Handle10.1097/00001813-200402000-00001

    Article  PubMed  Google Scholar 

  4. T Shirasaka Y Shimamoto M Fukushima (1993) ArticleTitleInhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats Cancer Res 53 4004–9 Occurrence Handle7689420 Occurrence Handle1:CAS:528:DyaK3sXmtFKqsrk%3D

    PubMed  CAS  Google Scholar 

  5. T Takechi K Nakano J Uchida A Mita K Toko S Takeda et al. (1997) ArticleTitleAntitumor activity and low intestinal toxicity of S-1, a new formulation of oral tegafur, in experimental tumor models in rats Cancer Chemother Pharmacol 39 205–11 Occurrence Handle8996521 Occurrence Handle10.1007/s002800050561 Occurrence Handle1:CAS:528:DyaK2sXis1ajsL4%3D

    Article  PubMed  CAS  Google Scholar 

  6. PA Johnes SB Baylin (2002) ArticleTitleThe fundamental role of epigenetic events in cancer Nat Rev Genet 3 415–28

    Google Scholar 

  7. PW Laird (2003) ArticleTitleThe power and the promise of DNA methylation markers Nat Rev Cancer 3 253–66 Occurrence Handle12671664 Occurrence Handle10.1038/nrc1045 Occurrence Handle1:CAS:528:DC%2BD3sXisFajtL4%3D

    Article  PubMed  CAS  Google Scholar 

  8. A Rashid JP Issa (2004) ArticleTitleCpG Island methylation in gastroenterologic neoplasia: a maturing field Gastroenterology 127 1578–88 Occurrence Handle15521024 Occurrence Handle10.1053/j.gastro.2004.09.007 Occurrence Handle1:CAS:528:DC%2BD2cXhtVKisrrN

    Article  PubMed  CAS  Google Scholar 

  9. C Cha RP Dematteo (2005) ArticleTitleMolecular mechanism in hepatocellular carcinoma development Best Pract Res Clin Gastroenterol 19 25–37 Occurrence Handle15757803 Occurrence Handle10.1016/j.bpg.2004.11.005 Occurrence Handle1:CAS:528:DC%2BD2MXitFCjtLo%3D

    Article  PubMed  CAS  Google Scholar 

  10. M Esteller G Gaidano SN Goodman V Zagonel D Capello B Botto et al. (2002) ArticleTitleHypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase and survival of patients with diffuse large B-cell lymphoma J Natl Cancer Inst 94 26–32 Occurrence Handle11773279 Occurrence Handle1:CAS:528:DC%2BD38Xit1amt7Y%3D

    PubMed  CAS  Google Scholar 

  11. Y Kitajima K Miyazaki S Matsukura M Tanaka M Sekiguchi (2003) ArticleTitleLoss of expression of DNA repair enzymes MGMT, hMLH1 and MSH2 during tumor progression in gastric cancer Gastric Cancer 6 86–95 Occurrence Handle12861399 Occurrence Handle1:CAS:528:DC%2BD2cXntVymt7k%3D

    PubMed  CAS  Google Scholar 

  12. S Matsukura K Miyazaki H Yakushiji A Ogawa K Harimaya Y Nakabeppu et al. (2001) ArticleTitleExpression and prognostic significance of O6-methylguanine-DNA methyltransferase in hepatocellular, gastric, and breast cancers Ann Surg Oncol 8 807–16 Occurrence Handle11776495 Occurrence Handle10.1007/s10434-001-0807-9 Occurrence Handle1:STN:280:DC%2BD38%2FkvVyntw%3D%3D

    Article  PubMed  CAS  Google Scholar 

  13. S Matsukura H Soejima T Nakagawachi H Yakushiji A Ogawa M Fukuhara et al. (2003) ArticleTitleCpG methylation of MGMT and MLH1 promoter in hepatocellular carcinoma associated with hepatitis viral infection Br J Cancer 88 521–9 Occurrence Handle12592365 Occurrence Handle10.1038/sj.bjc.6600743 Occurrence Handle1:CAS:528:DC%2BD3sXht1Glur0%3D

    Article  PubMed  CAS  Google Scholar 

  14. N Kohya K Miyazaki S Matsukura H Yakushiji Y Kitajima K Kitahara et al. (2002) ArticleTitleDeficient expression of O6-methylguanine-DNA methyltransferase combined with mismatch-repair proteins hMLH1 and MSH2 is related to poor prognosis in human biliary tract carcinoma Ann Surg Oncol 9 371–9 Occurrence Handle11986189

    PubMed  Google Scholar 

  15. Y Koga Y Kitajima A Miyoshi K Sato K Kitahara H Soejima et al. (2005) ArticleTitleTumor progression through epigenetic gene silencing of MGMT in human biliary tract cancers Ann Surg Oncol 12 354–63 Occurrence Handle15915369 Occurrence Handle10.1245/ASO.2005.07.020

    Article  PubMed  Google Scholar 

  16. M Esteller J Garcia-Foncillas E Andion SN Goodmasn OF Hidalgo V Vanaclocha et al. (2000) ArticleTitleInactivation of the DNA repair gene MGMT and clinical response of gliomas to alkylating agents N Engl J Med 343 1350–4 Occurrence Handle11070098 Occurrence Handle10.1056/NEJM200011093431901 Occurrence Handle1:CAS:528:DC%2BD3cXosFOltLg%3D

    Article  PubMed  CAS  Google Scholar 

  17. M Esteller (2003) ArticleTitleRelevance of DNA methylation in the management of cancer Lancet Oncol 4 351–8 Occurrence Handle12788407 Occurrence Handle10.1016/S1470-2045(03)01115-X Occurrence Handle1:CAS:528:DC%2BD3sXkt1OksL0%3D

    Article  PubMed  CAS  Google Scholar 

  18. JA Plumb G Strathdee J Sludden SB Kaye R Brown (2000) ArticleTitleReversal of drug resistance in human tumor xenografts by 2′-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter Cancer Res 60 6039–44 Occurrence Handle11085525 Occurrence Handle1:CAS:528:DC%2BD3cXotV2lsL8%3D

    PubMed  CAS  Google Scholar 

  19. Y Koga Y Kitajima A Miyoshi K Sato S Satoh K Miyazaki (2006) ArticleTitleThe significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer J Gastroenterol 41 133–9 Occurrence Handle16568372 Occurrence Handle10.1007/s00535-005-1732-7 Occurrence Handle1:CAS:528:DC%2BD28XivFSgsrg%3D

    Article  PubMed  CAS  Google Scholar 

  20. T Nagasaka GB Sharp K Notohara T Kambara H Sasamoto H Isozaki et al. (2003) ArticleTitleHypermethylation of O6-methylguanine-DNA methyltransferase promoter may predict nonrecurrence after chemotherapy in colorectal cancer cases Clin Cancer Res 9 5306–12 Occurrence Handle14614014 Occurrence Handle1:CAS:528:DC%2BD3sXovVOnsr4%3D

    PubMed  CAS  Google Scholar 

  21. CN Arnold A Goel CR Boland (2003) ArticleTitleRole of hMLH1 promoter hypermethylation in drug resistance to 5FU in colorectal cancer cell lines Int. J. Cancer 106 66–73 Occurrence Handle12794758 Occurrence Handle10.1002/ijc.11176 Occurrence Handle1:CAS:528:DC%2BD3sXltFentL4%3D

    Article  PubMed  CAS  Google Scholar 

  22. MV Rijnsoever H Elsaleh D Joseph K McCaul B Iacopetta (2003) ArticleTitleCpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer Clin Cancer Res 9 2898–903 Occurrence Handle12912934

    PubMed  Google Scholar 

  23. InstitutionalAuthorNameJapanese Gastric Cancer Association (1998) ArticleTitleJapanese classification of gastric carcinoma—2nd English Edition Gastric Cancer 1 10–24 Occurrence Handle11957040 Occurrence Handle10.1007/PL00011681

    Article  PubMed  Google Scholar 

  24. R Paulin GW Grigg MW Davey AA Piper (1998) ArticleTitleUrea improves efficiency of bisulfite mediated sequencing of 5′-methylcytosine in genomic DNA Nucleic Acids Res 26 5009–10 Occurrence Handle9776768 Occurrence Handle10.1093/nar/26.21.5009 Occurrence Handle1:CAS:528:DyaK1cXnsVKgur0%3D

    Article  PubMed  CAS  Google Scholar 

  25. JG Herman R Graff S Myohanen BD Nelkin SB Baylin (1996) ArticleTitleMethylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proc Natl Acad Sci USA 93 9821–6 Occurrence Handle8790415 Occurrence Handle10.1073/pnas.93.18.9821 Occurrence Handle1:CAS:528:DyaK28XlsFeht7Y%3D

    Article  PubMed  CAS  Google Scholar 

  26. PG Corn MK Summers F Fogt AK Virmani AF Gazdar TD Halazonetis et al. (2003) ArticleTitleFrequent hypermethylation of the 5′ CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer Carcinogenesis 24 47–51 Occurrence Handle12538348 Occurrence Handle10.1093/carcin/24.1.47 Occurrence Handle1:CAS:528:DC%2BD3sXitlCgtLo%3D

    Article  PubMed  CAS  Google Scholar 

  27. CA Eads RV Lord K Wickramasighe TI Long SK Kurumboor L Berntein et al. (2001) ArticleTitleEpigenetic patterns in the progression of esophageal adenocarcinoma Cancer Res 61 3410–8 Occurrence Handle11309301 Occurrence Handle1:CAS:528:DC%2BD3MXjtFSjurk%3D

    PubMed  CAS  Google Scholar 

  28. AS Fleisher M Esteller S Wang G Tamura H Suzuki J Yin et al. (1999) ArticleTitleHypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability Cancer Res 59 1090–5 Occurrence Handle10070967 Occurrence Handle1:CAS:528:DyaK1MXhslelsLw%3D

    PubMed  CAS  Google Scholar 

  29. GH Kang S Lee HJ Lee KS Hwang (2004) ArticleTitleAberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia J Pathol 202 233–40 Occurrence Handle14743506 Occurrence Handle10.1002/path.1503 Occurrence Handle1:CAS:528:DC%2BD2cXhvVKjtL8%3D

    Article  PubMed  CAS  Google Scholar 

  30. N Oue Y Mitani J Motoshita S Matsumura K Yoshida H Kuniyasu et al. (2006) ArticleTitleAccumulation of DNA methylation is associated with tumor stage in gastric cancer Cancer 106 1250–9 Occurrence Handle16475210 Occurrence Handle10.1002/cncr.21754 Occurrence Handle1:CAS:528:DC%2BD28XjtVCrs7Y%3D

    Article  PubMed  CAS  Google Scholar 

  31. HM Nan YJ Song HY Yun JS Park H Kim (2005) ArticleTitleEffects of dietary intake and genetic factors on hypermethylation of the hMLH1 gene promoter in gastric cancer World J Gastroenterol 11 3834–41 Occurrence Handle15991278 Occurrence Handle1:CAS:528:DC%2BD2MXhtVemsLrJ

    PubMed  CAS  Google Scholar 

  32. HC Kang IJ Kim JH Park Y Shin HW Park JL Ku et al. (2004) ArticleTitlePromoter hypermethylation and silencing of the CHFR mitotic stress checkpoint gene in human gastric cancers Oncol Rep 12 129–33 Occurrence Handle15201973 Occurrence Handle1:CAS:528:DC%2BD2cXlvVeqsrs%3D

    PubMed  CAS  Google Scholar 

  33. A Satoh M Toyota F Itoh Y Sasaki H Suzuki K Ogi et al. (2003) ArticleTitleEpigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer Cancer Res 63 8606–13 Occurrence Handle14695171 Occurrence Handle1:CAS:528:DC%2BD3sXhtVSqtLjI

    PubMed  CAS  Google Scholar 

  34. TY Kim HJ Lee KS Hwang M Lee JW Kim YJ Bang et al. (2004) ArticleTitleMethylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma Lab Invest 84 479–84 Occurrence Handle14968123 Occurrence Handle10.1038/labinvest.3700060 Occurrence Handle1:CAS:528:DC%2BD2cXmtF2itrk%3D

    Article  PubMed  CAS  Google Scholar 

  35. T Waki G Tamura M Sato M Terashima S Nishizuka T Motoyama (2003) ArticleTitlePromoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia Cancer Sci 94 360–4 Occurrence Handle12824905 Occurrence Handle10.1111/j.1349-7006.2003.tb01447.x Occurrence Handle1:CAS:528:DC%2BD3sXkslCns7w%3D

    Article  PubMed  CAS  Google Scholar 

  36. N Oue J Motoshita H Yokozaki K Hayashi E Tahara K Taniyama et al. (2002) ArticleTitleDistinct promoter hypermethylation of p16INK4a, CDH1, and RNR-beta in intestinal, diffuse-adherent, and diffuse-scattered type gastric carcinomas J Pathol 198 55–9 Occurrence Handle12210063 Occurrence Handle10.1002/path.1170 Occurrence Handle1:CAS:528:DC%2BD38Xns1Wiurs%3D

    Article  PubMed  CAS  Google Scholar 

  37. L Wang F Zhang PP Wu XC Jiang L Zheng YY Yu (2006) ArticleTitleDisordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma World J Gastroenterol 12 4228–31 Occurrence Handle16830381 Occurrence Handle1:CAS:528:DC%2BD28XhtVyis7rJ

    PubMed  CAS  Google Scholar 

  38. M Serrano GJ Hannon D Beach (1993) ArticleTitleA new regulatory motif in cell-cycle control causing specific inhibit of cyclin D/CDK4 Nature 336 704–7 Occurrence Handle10.1038/366704a0

    Article  Google Scholar 

  39. LS Chow X Wang DL Kwong JS Sham SW Tsao JM Nicholls (2000) ArticleTitleEffect of p16INK4a on chemosensitivity in nasopharyngeal carcinoma cells Int J Oncol 17 135–40 Occurrence Handle10853030 Occurrence Handle1:CAS:528:DC%2BD3cXksV2ru7Y%3D

    PubMed  CAS  Google Scholar 

  40. M Simon D Voss TW Park-Simon R Mahlberg G Koster (2006) ArticleTitleRole of p16 and p14ARF in radio-and chemosensitivity of malignant glioma Oncol Rep 16 127–32 Occurrence Handle16786135 Occurrence Handle1:CAS:528:DC%2BD28Xntlans78%3D

    PubMed  CAS  Google Scholar 

  41. M Weller J Rieger C Grimmel G Erwin EG VanMeir ND Tribolet et al. (1998) ArticleTitlePredicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses Int J Cancer (Pred Oncol) 79 640–4 Occurrence Handle10.1002/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z Occurrence Handle1:CAS:528:DyaK1MXltlc%3D

    Article  CAS  Google Scholar 

  42. Y Iwadate S Mochizuki S Fujimoto H Namba S Sakiyama M Tgawa et al. (2000) ArticleTitleAlteration of CDKN/p16 in human astrocytic tumors is related with increased susceptibility to antimetabolite anticancer agents Int J Oncol 17 501–5 Occurrence Handle10938390 Occurrence Handle1:CAS:528:DC%2BD3cXlvFektbY%3D

    PubMed  CAS  Google Scholar 

  43. S Stone P Dayananth A Kamb (1996) ArticleTitleReversible, p16 mediated cell cycle arrest as protection from chemotherapy Cancer Res 56 3199–202 Occurrence Handle8764106 Occurrence Handle1:CAS:528:DyaK28Xktlaqsbw%3D

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Saga University Faculty of Medicine, 5-1-1 Nabeshima, Saga, 849-8501, Japan

    Mayumi Mitsuno, Yoshihiko Kitajima, Takao Ide, Kazuma Ohtaka, Masayuki Tanaka, Seiji Satoh & Kohji Miyazaki

Authors
  1. Mayumi Mitsuno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yoshihiko Kitajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takao Ide
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazuma Ohtaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Masayuki Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seiji Satoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Kohji Miyazaki
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mitsuno, M., Kitajima, Y., Ide, T. et al. Aberrant methylation of p16 predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients. J Gastroenterol 42, 866–873 (2007). https://doi.org/10.1007/s00535-007-2113-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-007-2113-1

Key words

Search

Navigation